Screening of significant oncogenic changes in air pollution-related lung cancer in Chinese population

被引:0
作者
Kanwal, Madiha [1 ,2 ]
Ding, Xiaojie [1 ]
Lin, Weiming [3 ]
Cao, Yi [1 ,3 ]
机构
[1] Chinese Acad Sci, Kunming Inst Zool, Lab Mol & Expt Pathol, 32 Jiaochang Donglu, Kunming, Yunnan, Peoples R China
[2] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China
[3] Longyan Univ, Coll Life Sci, Dept Vet Med, Longyan, Peoples R China
关键词
Air pollution; lung cancer; reverse transcriptase PCR (RT-PCR); HER2; EML4-ALK; CD74-ROS1; GROWTH-FACTOR RECEPTOR; NEVER-SMOKERS; PHASE-II; MUTATION; HER2; PCR; ADENOCARCINOMA; TRASTUZUMAB; EXPRESSION; FISH;
D O I
10.21037/tcr-19-1314
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Air pollution-related lung cancer has been considered as a deteriorating public health problem worldwide, particularly in developing countries. The highly air polluted regions in China particularly Xuanwei and Fuyuan counties have markedly high lung cancer rates and are considered as good models to study air pollution-related lung cancer. The present study investigated the clinically significant oncogenes in air pollution-related lung cancers. Methods: A combination of reverse transcriptase PCR (RT-PCR) and DNA sequencing was applied to examine the expression, mutations, or fusions of target genes, including human epidermal growth factor receptor 2 (HER2), echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase (EML4-ALK), and cluster of differentiation 74-ROS proto-oncogene 1 (CD74-ROS1). Results: Of the 82 patients with lung cancer, 20.7% (17/82) exhibited HER2 up-regulation, and 1.2% (1/82) harbored HER2 insertion at exon 20. HER2 overexpression was not associated with air pollution levels and smoking status. A total of 6.1% (5/82) samples exhibited ALK gene rearrangements; two belonged to EML4-E2 + ALK-E20 and three were EML4-E13 + ALK-E20; all the five cases occurred either in smokers or in patients from the most air-polluted region. A total of 3.6% (3/82) carried the CD74-ROS1 fusion gene (CD74-E6 + ROS1-E34); the fusion event was not statistically associated with air pollution levels. Conclusions: The high rates of prevalence indicated in the present study suggest that the screening of HER2 overexpression and EML4-ALK fusion events may assist in guiding treatment in air pollution-related lung cancer; the RT-PCR-based test proposed in this study may be a useful tool in clinical applications to screen these genetic changes.
引用
收藏
页码:4341 / 4353
页数:13
相关论文
共 51 条
[1]   ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers [J].
Bergethon, Kristin ;
Shaw, Alice T. ;
Ou, Sai-Hong Ignatius ;
Katayama, Ryohei ;
Lovly, Christine M. ;
McDonald, Nerina T. ;
Massion, Pierre P. ;
Siwak-Tapp, Christina ;
Gonzalez, Adriana ;
Fang, Rong ;
Mark, Eugene J. ;
Batten, Julie M. ;
Chen, Haiquan ;
Wilner, Keith D. ;
Kwak, Eunice L. ;
Clark, Jeffrey W. ;
Carbone, David P. ;
Ji, Hongbin ;
Engelman, Jeffrey A. ;
Mino-Kenudson, Mari ;
Pao, William ;
Iafrate, A. John .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) :863-870
[2]  
Brabender J, 2001, CLIN CANCER RES, V7, P1850
[3]   The new World Health Organization classification of lung tumours [J].
Brambilla, E ;
Travis, WD ;
Colby, TV ;
Corrin, B ;
Shimosato, Y .
EUROPEAN RESPIRATORY JOURNAL, 2001, 18 (06) :1059-1068
[4]   Prevalence and causes of air pollution and lung cancer in Xuanwei City and Fuyuan County, Yunnan Province, China [J].
Yi Cao ;
Huaping Gao .
Frontiers of Medicine, 2012, 6 (2) :217-220
[5]   China tackles the health effects of air pollution [J].
Chen, Zhu ;
Wang, Jin-Nan ;
Ma, Guo-Xia ;
Zhang, Yan-Shen .
LANCET, 2013, 382 (9909) :1959-1960
[6]   HER2 and ESR1 mRNA expression levels and response to neoadjuvant trastuzumab plus chemotherapy in patients with primary breast cancer [J].
Denkert, Carsten ;
Huober, Jens ;
Loibl, Sibylle ;
Prinzler, Judith ;
Kronenwett, Ralf ;
Darb-Esfahani, Silvia ;
Brase, Jan C. ;
Solbach, Christine ;
Mehta, Keyur ;
Fasching, Peter A. ;
Sinn, Bruno V. ;
Engels, Knut ;
Reinisch, Mattea ;
Hansmann, Martin-Leo ;
Tesch, Hans ;
von Minckwitz, Gunter ;
Untch, Michael .
BREAST CANCER RESEARCH, 2013, 15 (01)
[7]   Crucial clues [J].
Deweerdt, Sarah .
NATURE, 2014, 513 (7517) :S12-S13
[8]   Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer [J].
Gatzemeier, U ;
Groth, G ;
Butts, C ;
Van Zandwijk, N ;
Shepherd, F ;
Ardizzoni, A ;
Barton, C ;
Ghahramani, P ;
Hirsh, V .
ANNALS OF ONCOLOGY, 2004, 15 (01) :19-27
[9]  
Heinmöller P, 2003, CLIN CANCER RES, V9, P5238
[10]   Droplet Digital™ PCR quantitation of HER2 expression in FFPE breast cancer samples [J].
Heredia, Nicholas J. ;
Belgrader, Phillip ;
Wang, Shenglong ;
Koehler, Ryan ;
Regan, Jack ;
Cosman, Angela M. ;
Saxonov, Serge ;
Hindson, Benjamin ;
Tanner, Stephanie C. ;
Brown, Alexandra S. ;
Karlin-Neumann, George .
METHODS, 2013, 59 (01) :S20-S23